Literature DB >> 16941571

Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.

Jia-Xiang Wang1, Jie-Kai Yu, Li Wang, Qiu-Liang Liu, Jiao Zhang, Shu Zheng.   

Abstract

To find new biomarkers and establish serum protein fingerprint models for early diagnosis and preoperative staging of papillary thyroid carcinoma, we employed SELDI-TOF-MS and bioinformatics tools. A total of 116 samples were analyzed in this study. The first 80 samples were analyzed by SELDI-TOF-MS and two biomarker patterns were identified. Pattern 1 distinguishes patients with papillary thyroid carcinoma from healthy individuals. Pattern 2 distinguishes papillary thyroid carcinoma from benign thyroid nodes. The remaining 29 samples were analyzed on the second day and served as an independent test set. The analysis of this independent test set yielded a specificity of 80.0% and a sensitivity of 88.9% for pattern 1 and a specificity of 80.0% and a sensitivity of 80.0% for pattern 2. Two additional biomarker patterns were identified to distinguish different stages of the papillary thyroid carcinoma (pattern 3) with an accuracy of 77.1% and different pathological types of thyroid carcinoma (pattern 4) with an accuracy of 88.1%. Taken together, the SELDI-TOF-MS technique combined with bioinformatics approaches can not only facilitate the discovery of better biomarkers for papillary thyroid carcinoma but also provide a useful tool for molecular diagnosis in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941571     DOI: 10.1002/pmic.200500833

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

1.  Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis.

Authors:  Minmin Wang; Qiu Jin; Haiyan Tu; Youying Mao; Jiekai Yu; Ying Chen; Zhangfei Shou; Qiang He; Jianyong Wu; Shu Zheng; Jianghua Chen
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphoma.

Authors:  Wenhong Xu; Yue Hu; Xuexin He; Jun Li; Tao Pan; Hai Liu; Xianguo Wu; Hong He; Weiting Ge; Jiekai Yu; Qichun Wei; Shu Zheng; Suzhan Zhang; Yiding Chen
Journal:  Tumour Biol       Date:  2014-11-20

3.  Novel circulating protein biomarkers for thyroid cancer determined through data-independent acquisition mass spectrometry.

Authors:  Dandan Li; Jie Wu; Zhongjuan Liu; Ling Qiu; Yimin Zhang
Journal:  PeerJ       Date:  2020-07-06       Impact factor: 2.984

4.  Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.

Authors:  Shuanying Yang; Yandong Nan; Yingxuan Tian; Wei Zhang; Bin Zhou; Lina Bu; Shufen Huo; Guoan Chen; Jiekai Yu; Shu Zheng
Journal:  Med Oncol       Date:  2008-02-26       Impact factor: 3.064

5.  Proteomic profiling of follicular and papillary thyroid tumors.

Authors:  Anastasios Sofiadis; Susanne Becker; Ulf Hellman; Lina Hultin-Rosenberg; Andrii Dinets; Mykola Hulchiy; Jan Zedenius; Göran Wallin; Theodoros Foukakis; Anders Höög; Gert Auer; Janne Lehtiö; Catharina Larsson
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

6.  Identification of Kininogen 1 as a Serum Protein Marker of Colorectal Adenoma in Patients with a Family History of Colorectal Cancer.

Authors:  Jiekai Yu; Yanqin Huang; Chen Lin; Xiaofen Li; Xuefeng Fang; Chenhan Zhong; Ying Yuan; Shu Zheng
Journal:  J Cancer       Date:  2018-03-08       Impact factor: 4.207

7.  Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.

Authors:  Fu-Ming Qiu; Jie-Kai Yu; Yi-Ding Chen; Qi-Feng Jin; Mei-Hua Sui; Jian Huang
Journal:  J Exp Clin Cancer Res       Date:  2009-09-09

Review 8.  Applications of SELDI-MS technology in oncology.

Authors:  L C Whelan; K A R Power; D T McDowell; J Kennedy; W M Gallagher
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

9.  The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.

Authors:  Raymon H Grogan; Elliot J Mitmaker; Orlo H Clark
Journal:  Cancers (Basel)       Date:  2010-05-20       Impact factor: 6.639

10.  Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.

Authors:  Jiekai Yu; Xiaohui Zhai; Xiaofen Li; Chenhan Zhong; Cheng Guo; Fuquan Yang; Ying Yuan; Shu Zheng
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.